Human Neurospheroid Arrays for In Vitro Studies of Alzheimer’s Disease
暂无分享,去创建一个
[1] Z. Hall. Cancer , 1906, The Hospital.
[2] A. Baer. The genetic perspective , 1977 .
[3] G. Curt,et al. The pharmacology and clinical use of methotrexate. , 1983, The New England journal of medicine.
[4] M. Weinblatt,et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. , 1985, The New England journal of medicine.
[5] R. Tanzi,et al. Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.
[6] Robert W Berry,et al. Tau, tangles, and Alzheimer's disease. , 2005, Biochimica et biophysica acta.
[7] Michael S. Krzemnicki,et al. Challenges and perspectives , 2009 .
[8] J. Götz,et al. Animal models of Alzheimer's disease and frontotemporal dementia , 2008, Nature Reviews Neuroscience.
[9] Krishanu Saha,et al. Technical challenges in using human induced pluripotent stem cells to model disease. , 2009, Cell stem cell.
[10] Ali Khademhosseini,et al. Controlled-size embryoid body formation in concave microwell arrays. , 2010, Biomaterials.
[11] G. Whitesides,et al. Soft lithography for micro- and nanoscale patterning , 2010, Nature Protocols.
[12] Shoji Takeuchi,et al. A neurospheroid network-stamping method for neural transplantation to the brain. , 2010, Biomaterials.
[13] Y. Hatano,et al. Folate antagonist, methotrexate induces neuronal differentiation of human embryonic stem cells transplanted into nude mouse retina , 2010, Neuroscience Letters.
[14] Hiroyuki Miyoshi,et al. Self-formation of functional adenohypophysis in three-dimensional culture , 2011, Nature.
[15] Sung-Ho Kim,et al. Neurotoxicity of methotrexate to hippocampal cells in vivo and in vitro. , 2011, Biochemical pharmacology.
[16] J. Chin,et al. Selecting a mouse model of Alzheimer's disease. , 2010, Methods in molecular biology.
[17] S. Leurgans,et al. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. , 2011, Archives of neurology.
[18] Erika Pastrana,et al. Eyes wide open: a critical review of sphere-formation as an assay for stem cells. , 2011, Cell stem cell.
[19] A. Kriegstein,et al. Development and Evolution of the Human Neocortex , 2011, Cell.
[20] Kristopher L. Nazor,et al. Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells , 2012, Nature.
[21] R. Tanzi,et al. iPSCs to the rescue in Alzheimer's research. , 2012, Cell stem cell.
[22] L. Goldstein,et al. Alzheimer's disease in a dish: promises and challenges of human stem cell models. , 2012, Human molecular genetics.
[23] H. Okano,et al. Establishment of Induced Pluripotent Stem Cells from Centenarians for Neurodegenerative Disease Research , 2012, PloS one.
[24] Zhong Zhong,et al. Prevention of β-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent kinases and associated cell cycle events. , 2013, Stem cell research.
[25] W. Thies,et al. 2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.
[26] J. Kessler,et al. Stem cell derived basal forebrain cholinergic neurons from Alzheimer’s disease patients are more susceptible to cell death , 2014, Molecular Neurodegeneration.
[27] Katsuhiro Yoshikawa,et al. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. , 2013, Cell stem cell.
[28] Kun Zhang,et al. The presenilin-1 ΔE9 mutation results in reduced γ-secretase activity, but not total loss of PS1 function, in isogenic human stem cells. , 2013, Cell reports.
[29] Adrian Ranga,et al. Drug discovery through stem cell-based organoid models. , 2014, Advanced drug delivery reviews.
[30] Joana Galvao,et al. Unexpected low‐dose toxicity of the universal solvent DMSO , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] D. Selkoe,et al. The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons. , 2014, Human molecular genetics.
[32] Ottavio Arancio,et al. Characterization and Molecular Profiling of PSEN1 Familial Alzheimer's Disease iPSC-Derived Neural Progenitors , 2014, PloS one.
[33] Basavaraj Hooli,et al. A three-dimensional human neural cell culture model of Alzheimer’s disease , 2014, Nature.
[34] David L Kaplan,et al. Bioengineered functional brain-like cortical tissue , 2014, Proceedings of the National Academy of Sciences.
[35] S. Socorro,et al. Paradoxical and contradictory effects of imatinib in two cell line models of hormone‐refractory prostate cancer , 2015, The Prostate.
[36] R. Tanzi,et al. γ‐Secretase modulators reduce endogenous amyloid β42 levels in human neural progenitor cells without altering neuronal differentiation , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] K. Blennow,et al. APP Metabolism Regulates Tau Proteostasis in Human Cerebral Cortex Neurons , 2015, Cell reports.
[38] Diane Hoffman-Kim,et al. Three-Dimensional Neural Spheroid Culture: An In Vitro Model for Cortical Studies. , 2015, Tissue engineering. Part C, Methods.
[39] Young Hye Kim,et al. Alzheimer's in 3D culture: Challenges and perspectives , 2015, BioEssays : news and reviews in molecular, cellular and developmental biology.
[40] S. Conroy,et al. Serum-Induced Differentiation of Glioblastoma Neurospheres Leads to Enhanced Migration/Invasion Capacity That Is Associated with Increased MMP9 , 2015, PloS one.
[41] Young Hye Kim,et al. A 3D human neural cell culture system for modeling Alzheimer's disease , 2015, Nature Protocols.
[42] R. Tanzi,et al. Recapitulating amyloid β and tau pathology in human neural cell culture models: clinical implications. , 2015, US neurology.
[43] Jung Keun Hyun,et al. Three-dimensional brain-on-a-chip with an interstitial level of flow and its application as an in vitro model of Alzheimer's disease. , 2015, Lab on a chip.
[44] DoYeun Park,et al. Networked neural spheroid by neuro-bundle mimicking nervous system created by topology effect , 2015, Molecular Brain.
[45] Norie Tooi,et al. The modeling of Alzheimer's disease by the overexpression of mutant Presenilin 1 in human embryonic stem cells. , 2016, Biochemical and biophysical research communications.
[46] Christine Van Broeckhoven,et al. The genetic landscape of Alzheimer disease: clinical implications and perspectives , 2015, Genetics in Medicine.
[47] Madeline A. Lancaster,et al. Dishing out mini-brains: Current progress and future prospects in brain organoid research , 2016, Developmental biology.
[48] Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1. , 2016, Stem cell research.
[49] G. Waldemar,et al. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1. , 2016, Stem cell research.
[50] Marc Tessier-Lavigne,et al. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9 , 2016, Nature.
[51] L. Tsai,et al. Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer’s Disease Phenotypes , 2016, PloS one.
[52] B. Strooper,et al. Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics , 2016 .
[53] Madeline A. Lancaster,et al. Stem Cell Models of Human Brain Development. , 2016, Cell stem cell.
[54] P. Arlotta,et al. The promises and challenges of human brain organoids as models of neuropsychiatric disease , 2016, Nature Medicine.
[55] D. Price,et al. Building brains in a dish: Prospects for growing cerebral organoids from stem cells , 2016, Neuroscience.
[56] Han-Kyu Lee,et al. Three Dimensional Human Neuro-Spheroid Model of Alzheimer’s Disease Based on Differentiated Induced Pluripotent Stem Cells , 2016, PloS one.
[57] Jessica E Young,et al. Defective Transcytosis of APP and Lipoproteins in Human iPSC-Derived Neurons with Familial Alzheimer's Disease Mutations. , 2016, Cell reports.
[58] R. Bateman,et al. Stop Alzheimer’s before it starts , 2017, Nature.
[59] Lin Cheng,et al. Selective and effective targeting of chronic myeloid leukemia stem cells by topoisomerase II inhibitor etoposide in combination with imatinib mesylate in vitro , 2017, Cell biology international.
[60] C. Revnic,et al. THE EFFECT OF SERUM FACTORS FROM PATIENTS WITH/WITHOUT ESSENTIAL HYPERTENSIOIN ON MEMBRANE RECEPTORS FROM RAT CEREBRAL CORTEX VASCULAR AND CARDIAC MUSCLE CELLS , 2017, Alzheimer's & Dementia.
[61] Jonathan A. Bernstein,et al. Assembly of functionally integrated human forebrain spheroids , 2017, Nature.
[62] B. Cullen,et al. Update on Alzheimer's Disease Therapy and Prevention Strategies. , 2017, Annual review of medicine.
[63] Clinical Implications. , 2017, Hypertension.
[64] Mehdi Jorfi,et al. Three‐Dimensional Models of the Human Brain Development and Diseases , 2018, Advanced healthcare materials.